Michael B Hoffman
Chairman and CEO, Director at Translational Development Acquisition Corp. (TDAC) since December 2024
Michael B Hoffman has filed 22 insider reports with the SEC since July 2021, as director at Annovis Bio, Inc. (ANVS) and chairman and CEO and director at Translational Development Acquisition Corp. (TDAC). In the last 12 months Michael B Hoffman bought $7M of stock on the open market. In the latest filing, on November 6, 2026, Michael B Hoffman bought 5,000,000 shares of Annovis Bio, Inc. (ANVS) for $5M at an average of $1.00.
- Filings
- 22
- Companies
- 2
- Bought on market
- $9.1M
- Sold on market
- None
Companies where Michael B Hoffman is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 8,364,883 | $9.1M | $1.32 | $0.7113-46% | Nov 6, 2026 | ||
| Chairman and CEO, Directorsince December 2024 | $10.92 | May 29, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Nov 6, 2026+$5MANVSDirector Hoffman Michael B bought $5,000,000 worth of shares (5,000,000 units at $1.00), increasing direct ownership by 149% to 8,364,883 unitsForm 4Open-market purchase
- May 27, 2026TDACSEC Form 4 filed by Chairman and CEO Hoffman Michael BForm 4Open-market purchase
- May 20, 2026+$143KANVSDirector Hoffman Michael B bought $142,779 worth of shares (76,344 units at $1.87), increasing direct ownership by 2% to 3,364,883 unitsForm 4Open-market purchase
- Apr 2, 2026+$1.5MANVSSEC Form 4 filed by Hoffman Michael BForm 4Open-market purchase
- Dec 8, 2025+$194KANVSDirector Hoffman Michael B bought $193,794 worth of shares (45,000 units at $4.31), increasing direct ownership by 2% to 2,574,739 unitsForm 4Open-market purchase
- Nov 24, 2025+$160KANVSAmendment: Director Hoffman Michael B bought $159,886 worth of shares (39,200 units at $4.08), increasing direct ownership by 2% to 2,529,739 unitsForm 4/AOpen-market purchase
- Nov 24, 2025+$160KANVSDirector Hoffman Michael B bought $159,886 worth of shares (39,200 units at $4.08), increasing direct ownership by 2% to 2,519,739 unitsForm 4Open-market purchase
- Nov 21, 2025+$69.9KANVSDirector Hoffman Michael B bought $69,900 worth of shares (20,000 units at $3.50), increasing direct ownership by 0.81% to 2,490,539 unitsForm 4Open-market purchase
- Nov 14, 2025+$31.7KANVSDirector Hoffman Michael B bought $31,650 worth of shares (15,000 units at $2.11), increasing direct ownership by 0.61% to 2,470,539 unitsForm 4Open-market purchase
- Oct 28, 2025+$2MANVSDirector Hoffman Michael B bought $2,000,000 worth of shares (975,610 units at $2.05), increasing direct ownership by 66% to 2,455,539 unitsForm 4Open-market purchase
- Aug 29, 2025ANVSDirector Hoffman Michael B was granted 15,000 shares, increasing direct ownership by 1% to 1,479,929 unitsForm 4Grant or award
- Aug 19, 2025ANVSDirector Hoffman Michael B was granted 18,645 shares, increasing direct ownership by 1% to 1,464,929 unitsForm 4Grant or award
- Jun 13, 2025ANVSDirector Hoffman Michael B was granted 25,001 shares, increasing direct ownership by 2% to 1,446,284 unitsForm 4Grant or award
- May 29, 2025ANVSDirector Hoffman Michael B was granted 5,000 shares, increasing direct ownership by 0.35% to 1,421,283 unitsForm 4Grant or award
- Dec 20, 2024TDACMichael B Hoffman became an insiderForm 3New insider
- Nov 17, 2023ANVSSEC Form 4 filed by Director Hoffman Michael BForm 4Grant or award
- Nov 20, 2023ANVSHoffman Michael B was granted 163,880 shares (Amendment)Form 4Grant or award
- Nov 20, 2023ANVSHoffman Michael B was granted 164,745 sharesForm 4Grant or award
- Apr 7, 2023ANVSSEC Form 4 filed by Hoffman Michael BForm 4Grant or award
- Jan 18, 2023ANVSSEC Form 4 filed by Hoffman Michael BForm 4Grant or award
- Jan 4, 2022ANVSSEC Form 4: Hoffman Michael B exercised 37,142 shares at a strike of $3.59 and covered exercise/tax liability with 6,748 shares, increasing direct ownership by 2% to 1,416,283 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jul 7, 2021ANVSSEC Form 4 filed by Hoffman Michael BForm 4Grant or award
Compare Michael B Hoffman with
- Michael B Hoffman vs Maria-Luisa Maccecchini1 shared
- Michael B Hoffman vs Claudine Bruck1 shared
- Michael B Hoffman vs Andrew Walsh1 shared
- Michael B Hoffman vs Reid McCarthy1 shared
- Michael B Hoffman vs Mark K. White1 shared
- Michael B Hoffman vs Henry Hagopian III1 shared
Other insiders at the same companies
- Maria-Luisa MaccecchiniANVS
- Claudine BruckANVS
- Andrew WalshANVS
- Reid McCarthyANVS
- Christopher Kenneth JarrattTDAC
- Curtis T KeithTDAC
- TDAC Partners LLCTDAC
- E Premkumar ReddyTDAC
- Matthew KestenbaumTDAC
- Avanindra DasTDAC
Questions about Michael B Hoffman
- What is Michael B Hoffman's role at Translational Development Acquisition Corp.?
- Michael B Hoffman reports to the SEC as chairman and CEO and director at Translational Development Acquisition Corp. (TDAC), according to the latest filing on May 29, 2026. Michael B Hoffman has also filed as director at Annovis Bio, Inc. (ANVS).
- How many shares does Michael B Hoffman own?
- After the latest filing that states it, Michael B Hoffman directly owned 8,364,883 shares of Annovis Bio, Inc. (ANVS). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael B Hoffman bought or sold stock recently?
- The most recent open-market purchase was on November 6, 2026: bought 5,000,000 shares of Annovis Bio, Inc. (ANVS) for $5M at an average of $1.00.
- How do I get alerts when Michael B Hoffman files?
- Follow Michael B Hoffman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Michael B Hoffman filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Michael B Hoffman (SEC CIK 0001290208). Totals count each trade once, skipping amendments whose original is on file, from Jul 9, 2021 on. View on SEC EDGAR · Get this as JSON